Corcept Therapeutics Incorporated · NASDAQ:CORT
Guyer William received 328 Corcept Therapeutics Incorporated shares as an award (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Guyer William (Chief Development Officer) received 328 Corcept Therapeutics Incorporated shares as an award at US$113.38 for US$18,594, leaving 4,313 shares. Filed Sep 3, 2026 (Form 4).
- Awarded
- 328 shares
- Price
- US$113.38
- Value
- US$18,594
- Holding after
- 4,313 shares
- Trading plan
- No
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Award | 164 | US$113.38 | 4,149 | Direct |
| Sep 1, 2026 | Common Stock | Award | 164 | 4,313 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Guyer William
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Guyer William · Aug 12, 2026
- Form 4 · Guyer William · Aug 6, 2026
- Form 4 · Guyer William · Jul 8, 2026
- Form 4 · Guyer William · Jun 4, 2026
- Form 4 · Guyer William · Jun 3, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026